Skip to main content
Fig. 5 | Human Genomics

Fig. 5

From: Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression

Fig. 5

Estimating IPS scores, tumor purity, and TIIC components. A–E Boxplot showing differences of aggregated IPS z-score (A), antigen presentation (B), effector cells (C), suppressor cells (D), and checkpoint scores (E) between two risk groups. F–I A significant difference was shown in the immune score (F), stromal score (G), ESTIMATE score (H), and tumor purity (I) between the two risk groups. J Heatmap for the immune score, stromal score, ESTIMATE score and tumor purity, and immune cell infiltrates based on CIBERSORT, ssGSEA, QUANTISEQ, MCPCOUNTER, and EPIC algorithms in two risk groups. ***p < 0.001

Back to article page

Human Genomics

ISSN: 1479-7364